Orient Bio Stock

Orient Bio EBIT Margin

The EBIT Margin (Operating Margin) of Orient Bio (002630.KS) as of Jul 21, 2026 is -10.46 %. In the previous year, EBIT Margin (Operating Margin) was -2.31 % — a change of 353.70% (lower).

EBIT Margin

-10.46 %

YoY

353.70%

Last updated:

EBIT Margin (Operating Margin) of Orient Bio is 2026 -10.46 % . EBIT Margin (Operating Margin) of Orient Bio was 2025 -2.31 % . It decreases by 353.70% lower compared to the previous year.

For Orient Bio, the operating (EBIT) margin of -10.5% is up versus -20.6% a few years ago.

Access this data via the Eulerpool API

Orient Bio Stock analysis

What does Orient Bio do? Orient Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Bio stock

EBIT Margin (Operating Margin) of Orient Bio is -10.46 % in 2026.

Access this data via the Eulerpool API

Margins — Orient Bio

All Key Metrics — Orient Bio